Open AccessManifestation of cognitive impairments after a prior coronavirus infection COVID-19 in a patient with ApoE ε4 genotype
Author(s) -
M.S. Novikova Novikova,
Владимир Захаров,
Н. В. Вахнина
Publication year - 2021
Publication title -
rossijskij nevrologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.104
H-Index - 4
eISSN - 2686-7192
pISSN - 2658-7947
DOI - 10.30629/2658-7947-2021-26-2-25-29
Subject(s) - neuropsychology , apolipoprotein e , cognition , medicine , hyperintensity , disease , coronavirus , psychology , covid-19 , psychiatry , infectious disease (medical specialty) , magnetic resonance imaging , radiology
Nowadays, the novel coronavirus infection (COVID-19) pandemic is one of the most important global health problems. There is increasing evidence that COVID-19 affects central and peripheral nervous system as well. The paper presents a clinical case of a 47 old patient with the ApoE ε4 haplotype and family history of Alzheimer’s disease who developed cognitive impairment after acute COVID-19. Before the infection the patient has no cognitive complaints and preserved everyday activity. After novel coronavirus infection, which was observed in mild form, the patient had started to complain on constant excessive forgetfulness. Neuropsychological assessment confirmed the presence of pre-mild cognitive impairment of predominantly single domain amnestic type. However, brain MRI showed only subtle periventricular white matter changes usually attributed to small vessel disease. Memory complaints were observed for 3 months of follow up despite intensive cognitive training, optimization of lifestyle and therapy with choline alphoscerate. Probable links between coronavirus infectious and cognitive impairment manifestation are discussed. There is data that ApoE ε4 haplotype is associated with increase of microglia mediated neuro-inflammation and it can be significant for accelerating of progression of neurodegenerative diseases after COVID-19. Further follow up of the patient is necessary for determination of nosological diagnosis explaining manifested predominantly amnestic type pre-mild cognitive impairment.